CION Ameerpet
Hyperplasia · Reviewed by CION Oncologists · NABH Accredited
Follow-Up After Hyperplasia — Why the Biopsies Matter
Here is the single most common failure in hyperplasia care, and it is not a clinical one. Treatment starts, the bleeding settles within weeks, the woman reasonably concludes the problem is solved, and the follow-up biopsy is never attended. The difficulty is that bleeding settling proves nothing about the lining — progestogen controls bleeding readily, including while hyperplasia is still present. The only way to know the lining has actually recovered is to sample it. This page explains what each follow-up biopsy is checking for and why the schedule is worth completing even when you feel entirely well.
- Bleeding settling is not regression — progestogen controls bleeding either way
- Each biopsy checks something specific — not a formality
- Intervals are set by your team — they differ with atypia and treatment
- Ask whose list you are on — lapsed recall is the practical failure
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Each Follow-Up Biopsy Is Checking
Intervals differ between women and are set by your team — they depend on whether atypia was present, which treatment you are on, and how the lining has responded. What does not differ is what each biopsy is looking for.
| Stage | What is being checked |
|---|---|
| The first biopsy on treatment | Is the lining responding at all? A lining that has not begun to regress prompts a review of the treatment, of whether it is being taken or the device is correctly in place, and of whether a focal lesion is being missed. |
| The biopsy confirming regression | The pivotal one. This is the result that establishes the lining has returned to normal, and it is the point at which treatment decisions — continuing, stopping, or attempting conception — can be made on evidence rather than assumption. See hyperplasia and fertility. |
| Biopsies after regression | Watching for recurrence. The hormonal state that caused the hyperplasia usually persists, so the lining can revert. Detecting that early is straightforward; detecting it years later after symptoms return is less so. See can hyperplasia come back. |
| Any biopsy, checking for atypia | Running throughout. The appearance of atypia where there was none changes the management substantially, because atypical hyperplasia is precancerous. This is the finding surveillance exists to catch. See atypical hyperplasia. |
| Long-term surveillance | For women whose risk factors persist — continuing anovulation, significant obesity — monitoring may continue well beyond the treatment course, sometimes indefinitely. That is not pessimism; it is a proportionate response to an ongoing cause. |
| Any new bleeding, at any time | Overrides the schedule entirely. New abnormal bleeding, and any bleeding after menopause, warrants assessment when it happens rather than at the next appointment. See bleeding after menopause. |
Ask for your schedule in writing, and ask whose list you are on. Surveillance that spans a year or more across changing clinics is exactly where recall quietly lapses. Keep your own note of dates as a backstop — it is the single most useful thing you can do.
Did You Know? The reason surveillance matters is not that hyperplasia without atypia is dangerous — its risk of progressing is low. It is that surveillance is how the small number of women whose disease behaves differently are identified while it is still easy to deal with. A follow-up biopsy that shows atypia where there was none before changes the plan entirely, and it is a change nobody could have predicted from how the woman felt. She would have had no symptoms and no reason to attend. That is precisely what a surveillance programme is for: it catches the exception, and the price is that the large majority attend appointments that confirm they are fine. Sources: RCOG/BSGE Green-top Guideline on the management of endometrial hyperplasia; WHO Classification of Tumours — Female Genital Tumours; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What a Follow-Up Biopsy Involves
Less than most women expect, which is worth knowing if anticipation is what is putting you off.
- Usually a clinic appointment, not theatre. A fine catheter through the cervix and a few minutes of sampling, with no anaesthetic. You walk out afterwards. See the Pipelle biopsy.
- A hormonal IUD can stay in place. A frequent worry and generally an unfounded one — sampling can normally be done around the device without disturbing it.
- It cramps, briefly. Simple pain relief an hour beforehand helps. If you have found it difficult before, ask about local anaesthetic to the cervix — it is available and is frequently not offered because it is not requested.
- An ultrasound is often done alongside. It looks at the lining and the cavity and helps identify a focal lesion that blind sampling might miss. See transvaginal ultrasound.
- Results take about a week. Ask who will contact you and by when. A result that nobody has agreed to chase is the second commonest failure after a missed appointment.
Lost Track of Your Follow-Up?
Biopsy and review in a single visit, and a written schedule so it does not lapse again.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Feeling Well Is Not the Same as Being Clear
Hyperplasia does not announce itself once bleeding is controlled. The biopsy is the only way to know.
Where Follow-Up Falls Apart
Five practical failures, all of them avoidable and all of them common.
Bleeding settles and the appointment is dropped
The dominant failure mode, and entirely understandable — the symptom that caused the alarm has gone, so the problem feels solved. Progestogen controls bleeding readily and can do so while hyperplasia persists in the lining. Feeling well is not evidence of regression, and only a biopsy can supply that evidence.
Nobody owns the recall
Surveillance may run for a year or more, sometimes across a change of clinic or doctor. Ask explicitly whose list you are on and when your next appointment is due, and keep your own diary. Where responsibility is assumed rather than assigned, appointments are quietly missed.
A result comes back and nobody acts on it
The biopsy is done, the report is filed, and no one contacts the patient. Ask before you leave who will tell you the result and by when — and chase it yourself if that date passes. It is not rudeness; it is the safeguard that makes the whole system work.
Treatment stopped without a confirming biopsy
Progestogen is planned for a defined period ending in a biopsy that confirms regression. Stopping when the course of tablets runs out, or when a device is removed for another reason, without that confirmation leaves the central question unanswered.
A new symptom saved for the next appointment
Surveillance detects what is present on the day it is done. New abnormal bleeding between appointments — and any bleeding after menopause — needs assessing when it arises, not at the scheduled visit. This is the one rule that overrides the calendar.
Not Sure Where You Are in the Schedule?
Bring your reports. We will work out where you are and set out what is due. The opinion is free.
When Follow-Up Can Stop
A reasonable question, and one with a real answer rather than an indefinite shrug.
- After regression is confirmed, and confirmed again. For hyperplasia without atypia in a woman whose risk factors have been addressed, surveillance can generally be brought to an end after repeated normal biopsies. Ask what the endpoint is at the outset.
- Later, where risk factors persist. Continuing anovulation or significant obesity means the stimulus is still present, so monitoring may sensibly continue longer. That is a proportionate response rather than an ominous one.
- Not at all, if the uterus has been removed. Hysterectomy ends the question entirely and is a legitimate choice for a woman who has completed her family and is tired of repeated cycles of treatment and biopsy.
- Differently, if atypia was ever found. Surveillance for atypical hyperplasia treated without surgery is more intensive and longer, because the underlying risk is higher. See atypical hyperplasia.
- Never for new symptoms. Being discharged from surveillance does not mean new bleeding is unimportant. It means you no longer attend routinely, not that you stop reporting things. See hyperplasia symptoms.
Why Surveillance Needs Someone to Own It
A year of appointments across a busy clinic is exactly where a plan quietly stops happening.
Follow-up you can actually keep
Scan and biopsy in one visit
One place for the whole pathway
Named MCh surgical oncologists
45-minute consultations
Costs explained before you commit
Take The Next Step
Keep Your Own Note of Dates
The simplest safeguard against a recall system that has lost you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Hyperplasia Follow-Up — Frequently Asked Questions
Why do I need more biopsies if my bleeding has stopped?
Because bleeding settling tells you the treatment is working on your symptom, not that the lining has returned to normal. Progestogen controls bleeding very effectively, and it can do so while hyperplasia persists in the endometrium. The only way to establish that the lining has actually regressed is to sample it and look. This matters most for the small number of women whose disease behaves differently — a follow-up biopsy showing atypia where there was none before changes the management entirely, and that woman would have had no symptoms and no reason to attend. Surveillance exists to catch the exception.
How often will I need a biopsy, and for how long?
That is set by your team rather than by a single universal schedule, and the reason is that it genuinely differs: whether atypia was present, which treatment you are on, how the lining has responded on earlier biopsies, and whether the underlying cause has been addressed all change the appropriate interval and duration. What you should have is a written schedule with dates, and an explicit answer about what the endpoint is. Women whose risk factors persist — continuing anovulation, significant obesity — may need longer surveillance, which is proportionate rather than ominous.
Does the hormonal IUD have to come out for the biopsy?
Generally no. Sampling can normally be performed around a levonorgestrel-releasing intrauterine system without disturbing it, and this worry stops some women attending unnecessarily. If there is a specific reason it needs removing — for example if you are moving on to attempt conception, or the device has reached the end of its effective life — that is planned deliberately rather than being a side effect of the biopsy. Ask when you book if you are unsure; a straight answer beforehand is easier than anxiety on the day.
The biopsy was uncomfortable last time. Is there anything that helps?
Yes, and it is worth asking rather than enduring. Simple pain relief taken about an hour beforehand helps most women. Local anaesthetic applied to the cervix is available and makes a real difference where the cervix is tight or you have found sampling difficult before — it is frequently not offered simply because it is not requested. Breathing slowly out through the cramp helps, as does asking the doctor to tell you before each step. If you genuinely cannot tolerate outpatient sampling, hysteroscopy with biopsy under sedation is an alternative, with the added benefit that the cavity is seen directly.
What if I have missed appointments and lost track?
Restart rather than avoid, and do so without embarrassment — this is extremely common and clinics see it constantly. Bring whatever reports you have, including your original biopsy result and any treatment details, and the position can usually be reconstructed and a fresh schedule set. What is not sensible is assuming that because time has passed and you feel well, the question has answered itself. If you have had any new abnormal bleeding, or any bleeding after menopause, that should be assessed promptly rather than folded into a routine appointment.
Medical disclaimer: This page provides general information about follow-up after treatment for endometrial hyperplasia, reviewed by a CION oncologist. It is not a substitute for individual medical advice. Surveillance intervals and duration are individualised and should be set by your treating team. Resolution of bleeding does not confirm that the endometrium has regressed. Any new abnormal bleeding, and any bleeding after menopause, should be assessed when it occurs rather than deferred to a scheduled appointment.